496 related articles for article (PubMed ID: 20614439)
21. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
22. Mycoplasma and Chlamydia pneumonia in pediatrics.
Nelson CT
Semin Respir Infect; 2002 Mar; 17(1):10-4. PubMed ID: 11891514
[TBL] [Abstract][Full Text] [Related]
23. Antibiotics for community acquired pneumonia in adult outpatients.
Bjerre LM; Verheij TJ; Kochen MM
Cochrane Database Syst Rev; 2004; (2):CD002109. PubMed ID: 15106168
[TBL] [Abstract][Full Text] [Related]
24. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
[TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
26. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
[TBL] [Abstract][Full Text] [Related]
27. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections.
Principi N; Esposito S
Lancet Infect Dis; 2001 Dec; 1(5):334-44. PubMed ID: 11871806
[TBL] [Abstract][Full Text] [Related]
28. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
[TBL] [Abstract][Full Text] [Related]
29. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia.
Fischer JE; Steiner F; Zucol F; Berger C; Martignon L; Bossart W; Altwegg M; Nadal D
Arch Pediatr Adolesc Med; 2002 Oct; 156(10):1005-8. PubMed ID: 12361446
[TBL] [Abstract][Full Text] [Related]
30.
Kumar S
Indian J Med Res; 2018 Jan; 147(1):23-31. PubMed ID: 29749357
[TBL] [Abstract][Full Text] [Related]
31. Antibiotics for community-acquired pneumonia in children.
Kabra SK; Lodha R; Pandey RM
Cochrane Database Syst Rev; 2010 Mar; (3):CD004874. PubMed ID: 20238334
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
[TBL] [Abstract][Full Text] [Related]
33. Antibiotics for community acquired pneumonia in adult outpatients.
Bjerre LM; Verheij TJ; Kochen MM
Cochrane Database Syst Rev; 2009 Oct; (4):CD002109. PubMed ID: 19821292
[TBL] [Abstract][Full Text] [Related]
34. [Community-acquired pneumonia in children: importance of Mycoplasma pneumoniae infections and efficacy of antibiotics].
Gendrel D; Raymond J; Moulin F; Iniguez JL; Truong M; Ravilly S; Chaussain M; Lebon P; Kalifa G
Presse Med; 1996 May; 25(17):793-7. PubMed ID: 8762275
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae.
Komatsu H; Tsunoda T; Inui A; Sogo T; Fujisawa T
Braz J Infect Dis; 2014; 18(3):294-9. PubMed ID: 24389284
[TBL] [Abstract][Full Text] [Related]
36. Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.
Gaillat J; Flahault A; deBarbeyrac B; Orfila J; Portier H; Ducroix JP; Bébéar C; Mayaud C
Eur J Epidemiol; 2005; 20(7):643-51. PubMed ID: 16119439
[TBL] [Abstract][Full Text] [Related]
37. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y
Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891
[TBL] [Abstract][Full Text] [Related]
38. [Azithromycin and bronchopulmonary infections].
Leophonte P
Pathol Biol (Paris); 1995 Jun; 43(6):534-41. PubMed ID: 8539078
[TBL] [Abstract][Full Text] [Related]
39. [Critical analysis of antibiotic therapy of acute respiratory infections caused by Mycoplasma pneumoniae].
Kuzman I; Petricević I
Plucne Bolesti; 1989; 41(1-2):13-7. PubMed ID: 2508137
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan.
Wu PS; Chang LY; Lin HC; Chi H; Hsieh YC; Huang YC; Liu CC; Huang YC; Huang LM
Pediatr Pulmonol; 2013 Sep; 48(9):904-11. PubMed ID: 23169584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
